Shiloh
Editor, Senior Moderator
Source: https://www.who.int/publications/m/...xternal-situation-report--39---6-october-2024
Home/
Publications/
Overview/
Multi-country outbreak of mpox, External situation report #39 - 6 October 2024
Multi-country outbreak of mpox, External situation report #39 - 6 October 2024
Edition 39
6 October 2024
| Emergency Situational Updates
Multi-country outbreak of mpox, External situation report #39 - 6 October 2024
Overview
This is the 39th situation report for the multi-country outbreak of mpox, which provides an update on the mpox epidemiological situation in Africa as of 29 September 2024. Fourteen countries on the African continent have reported mpox cases in the last six weeks and are considered to have active outbreaks. The most affected country in 2024 continues to be the Democratic Republic of the Congo (5610 confirmed cases, 25 deaths), followed by Burundi (853 confirmed cases, no deaths), and Nigeria (78 confirmed cases, no deaths).
This edition provides a detailed subnational focus on the Democratic Republic of the Congo province of North Kivu where about a third (34%) of the reported confirmed cases are individuals living in camps for Internally Displaced People (IDP) and approximately 75% of mpox cases are among children 0 – 17 years old, evenly distributed between males and females. Currently, available case investigation and sequencing data suggest that mpox transmission in this province is exclusively human-to-human, with about a third (34%) of the cases reporting sexual contact as the mode of transmission, and among these cases, over half are reported to be sex workers (52%).
Operational updates as of 4 October 2024 are included. WHO approved the first mpox diagnostic test for emergency use, the Alinity m MPXV, on 3 October 2024 and 265 000 doses of MVA-BN vaccines have been dispatched from Kinshasa to several “hubs” in the Democratic Republic of the Congo.
Home/
Publications/
Overview/
Multi-country outbreak of mpox, External situation report #39 - 6 October 2024
Multi-country outbreak of mpox, External situation report #39 - 6 October 2024
Edition 39
6 October 2024
| Emergency Situational Updates
Multi-country outbreak of mpox, External situation report #39 - 6 October 2024
Overview
This is the 39th situation report for the multi-country outbreak of mpox, which provides an update on the mpox epidemiological situation in Africa as of 29 September 2024. Fourteen countries on the African continent have reported mpox cases in the last six weeks and are considered to have active outbreaks. The most affected country in 2024 continues to be the Democratic Republic of the Congo (5610 confirmed cases, 25 deaths), followed by Burundi (853 confirmed cases, no deaths), and Nigeria (78 confirmed cases, no deaths).
This edition provides a detailed subnational focus on the Democratic Republic of the Congo province of North Kivu where about a third (34%) of the reported confirmed cases are individuals living in camps for Internally Displaced People (IDP) and approximately 75% of mpox cases are among children 0 – 17 years old, evenly distributed between males and females. Currently, available case investigation and sequencing data suggest that mpox transmission in this province is exclusively human-to-human, with about a third (34%) of the cases reporting sexual contact as the mode of transmission, and among these cases, over half are reported to be sex workers (52%).
Operational updates as of 4 October 2024 are included. WHO approved the first mpox diagnostic test for emergency use, the Alinity m MPXV, on 3 October 2024 and 265 000 doses of MVA-BN vaccines have been dispatched from Kinshasa to several “hubs” in the Democratic Republic of the Congo.